[HTML][HTML] How to manage the transplant question in myelofibrosis
K Ballen - Blood cancer journal, 2012 - nature.com
Allogeneic stem cell transplantation remains the only curative therapy for myelofibrosis.
Despite advances in transplant, the morbidity and the mortality of the procedure necessitate …
Despite advances in transplant, the morbidity and the mortality of the procedure necessitate …
[PDF][PDF] How to manage the transplant question in myelofibrosis
K Ballen - Blood Cancer Journal, 2012 - scienceopen.com
Allogeneic stem cell transplantation remains the only curative therapy for myelofibrosis.
Despite advances in transplant, the morbidity and the mortality of the procedure necessitate …
Despite advances in transplant, the morbidity and the mortality of the procedure necessitate …
[PDF][PDF] How to manage the transplant question in myelofibrosis
K Ballen - Blood Cancer Journal, 2012 - Citeseer
Allogeneic stem cell transplantation remains the only curative therapy for myelofibrosis.
Despite advances in transplant, the morbidity and the mortality of the procedure necessitate …
Despite advances in transplant, the morbidity and the mortality of the procedure necessitate …
How to manage the transplant question in myelofibrosis
K Ballen - Blood Cancer Journal, 2012 - search.proquest.com
Allogeneic stem cell transplantation remains the only curative therapy for myelofibrosis.
Despite advances in transplant, the morbidity and the mortality of the procedure necessitate …
Despite advances in transplant, the morbidity and the mortality of the procedure necessitate …
How to manage the transplant question in myelofibrosis
K Ballen - Blood cancer journal, 2012 - pubmed.ncbi.nlm.nih.gov
Allogeneic stem cell transplantation remains the only curative therapy for myelofibrosis.
Despite advances in transplant, the morbidity and the mortality of the procedure necessitate …
Despite advances in transplant, the morbidity and the mortality of the procedure necessitate …
[PDF][PDF] How to manage the transplant question in myelofibrosis
K Ballen - Blood Cancer Journal, 2012 - cyberleninka.org
Allogeneic stem cell transplantation remains the only curative therapy for myelofibrosis.
Despite advances in transplant, the morbidity and the mortality of the procedure necessitate …
Despite advances in transplant, the morbidity and the mortality of the procedure necessitate …
[HTML][HTML] How to manage the transplant question in myelofibrosis
K Ballen - Blood Cancer Journal, 2012 - ncbi.nlm.nih.gov
Allogeneic stem cell transplantation remains the only curative therapy for myelofibrosis.
Despite advances in transplant, the morbidity and the mortality of the procedure necessitate …
Despite advances in transplant, the morbidity and the mortality of the procedure necessitate …
[引用][C] How to manage the transplant question in myelofibrosis
K Ballen - Blood Cancer Journal, 2012 - cir.nii.ac.jp
How to manage the transplant question in myelofibrosis.
K Ballen - Blood Cancer Journal, 2012 - europepmc.org
Allogeneic stem cell transplantation remains the only curative therapy for myelofibrosis.
Despite advances in transplant, the morbidity and the mortality of the procedure necessitate …
Despite advances in transplant, the morbidity and the mortality of the procedure necessitate …